WO2007025774A3 - Cysteine protease inhibitors - Google Patents
Cysteine protease inhibitors Download PDFInfo
- Publication number
- WO2007025774A3 WO2007025774A3 PCT/EP2006/008578 EP2006008578W WO2007025774A3 WO 2007025774 A3 WO2007025774 A3 WO 2007025774A3 EP 2006008578 W EP2006008578 W EP 2006008578W WO 2007025774 A3 WO2007025774 A3 WO 2007025774A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protease inhibitors
- cysteine protease
- compounds
- processes
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Abstract
Substituted heteroaryl nitrile derivatives of Formula (I), processes for their preparation, pharmaceutical compositions comprising such compounds and use of the compounds as cysteine protease inhibitors are provided.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05381043 | 2005-09-02 | ||
EP05381043.8 | 2005-09-02 | ||
EP06110666.2 | 2006-03-03 | ||
EP06110666 | 2006-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007025774A2 WO2007025774A2 (en) | 2007-03-08 |
WO2007025774A3 true WO2007025774A3 (en) | 2007-04-26 |
Family
ID=37770277
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/008580 WO2007025776A2 (en) | 2005-09-02 | 2006-08-31 | Cysteine protease inhibitors |
PCT/EP2006/008578 WO2007025774A2 (en) | 2005-09-02 | 2006-08-31 | Cysteine protease inhibitors |
PCT/EP2006/008579 WO2007025775A2 (en) | 2005-09-02 | 2006-08-31 | Cysteine protease inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/008580 WO2007025776A2 (en) | 2005-09-02 | 2006-08-31 | Cysteine protease inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2006/008579 WO2007025775A2 (en) | 2005-09-02 | 2006-08-31 | Cysteine protease inhibitors |
Country Status (4)
Country | Link |
---|---|
AR (2) | AR057110A1 (en) |
PE (2) | PE20070332A1 (en) |
TW (2) | TW200804352A (en) |
WO (3) | WO2007025776A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7271566B2 (en) | 2018-03-28 | 2023-05-11 | ハンリム ファーマシューティカル カンパニー リミテッド | 2-cyanopyrimidin-4-yl carbamate derivative or urea derivative or salt thereof and pharmaceutical composition containing same |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2030621A1 (en) * | 2007-08-21 | 2009-03-04 | Glaxo Group Limited | Novel substituted pyrimidines as cysteine protease inhibitors |
US20100009956A1 (en) * | 2006-10-30 | 2010-01-14 | Glaxo Group Limited , a corporation | Novel substituted pyrimidines as cysteine protease inhibitors |
CN101970007A (en) | 2007-06-08 | 2011-02-09 | 日本化学医药株式会社 | Therapeutic or prophylactic agent for cerebral aneurysm |
US20100331545A1 (en) | 2007-10-24 | 2010-12-30 | Nippon Chemiphar Co., Ltd. | Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
DE102008063561A1 (en) * | 2008-12-18 | 2010-08-19 | Bayer Cropscience Ag | Hydrazides, process for their preparation and their use as herbicides and insecticides |
CN102267964B (en) * | 2011-06-15 | 2014-06-18 | 浙江师范大学 | 3-hydroxy-2,3-dihydro-benzofuran derivatives as well as synthesis method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040249153A1 (en) * | 2001-08-30 | 2004-12-09 | Eva Altmann | Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
-
2006
- 2006-08-31 WO PCT/EP2006/008580 patent/WO2007025776A2/en active Application Filing
- 2006-08-31 WO PCT/EP2006/008578 patent/WO2007025774A2/en active Application Filing
- 2006-08-31 WO PCT/EP2006/008579 patent/WO2007025775A2/en active Application Filing
- 2006-08-31 PE PE2006001056A patent/PE20070332A1/en not_active Application Discontinuation
- 2006-08-31 AR ARP060103809A patent/AR057110A1/en not_active Application Discontinuation
- 2006-08-31 TW TW095132088A patent/TW200804352A/en unknown
- 2006-08-31 AR ARP060103810A patent/AR055624A1/en not_active Application Discontinuation
- 2006-08-31 TW TW095132087A patent/TW200804351A/en unknown
- 2006-08-31 PE PE2006001057A patent/PE20070612A1/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040249153A1 (en) * | 2001-08-30 | 2004-12-09 | Eva Altmann | Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7271566B2 (en) | 2018-03-28 | 2023-05-11 | ハンリム ファーマシューティカル カンパニー リミテッド | 2-cyanopyrimidin-4-yl carbamate derivative or urea derivative or salt thereof and pharmaceutical composition containing same |
Also Published As
Publication number | Publication date |
---|---|
AR057110A1 (en) | 2007-11-14 |
AR055624A1 (en) | 2007-08-29 |
PE20070612A1 (en) | 2007-06-23 |
WO2007025775A2 (en) | 2007-03-08 |
WO2007025774A2 (en) | 2007-03-08 |
TW200804351A (en) | 2008-01-16 |
WO2007025776A2 (en) | 2007-03-08 |
WO2007025776A3 (en) | 2007-05-03 |
TW200804352A (en) | 2008-01-16 |
PE20070332A1 (en) | 2007-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008013838A3 (en) | Pyridizinone derivatives | |
WO2007148185A3 (en) | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | |
NO20090295L (en) | Substituted heteroaryl derivatives | |
WO2008005877A3 (en) | Inhibitors of c-kit and uses thereof | |
WO2007125103A3 (en) | Benzamide glucokinase activators | |
WO2009156462A3 (en) | Organic compounds | |
WO2009099596A3 (en) | Macrocyclic serine protease inhibitors | |
WO2007072153A3 (en) | Carbonylamino pyrrolopyrazoles, potent kinase inhibitors | |
EA200500203A1 (en) | NEW METHOD OF SYNTHESIS AND NEW CRYSTAL FORM OF AGOMELATIN AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS | |
WO2009082701A8 (en) | Hcv protease inhibitors and uses thereof | |
WO2007067506A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
WO2009082152A3 (en) | Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient | |
WO2007030361A3 (en) | Benzimidazole thiophene compounds as plk inhibitors | |
WO2007065595A3 (en) | Xanthine derivatives, processes for preparing them and their uses | |
WO2007090749A3 (en) | Benzamide and heteroarene derivatives as cetp inhibitors | |
WO2009105969A8 (en) | Epothilone analogues, their pharmaceutical compositions, their use and their preparations | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
WO2007025774A3 (en) | Cysteine protease inhibitors | |
WO2005005389A3 (en) | Malonamide derivatives | |
WO2006134499A3 (en) | 2-(1h-indolylsulfanyl)-aryl amine derivatives | |
TW200624429A (en) | Novel cysteine protease inhibitors | |
WO2007068728A3 (en) | N-substituted pyrrolopyridinones active as kinase inhibitors | |
WO2006031929A3 (en) | Thiazolopyridine kinase inhibitors | |
WO2006110173A3 (en) | Novel compounds | |
WO2007017758A3 (en) | Novel cysteine protease inhibitors and their therapeutic applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06777150 Country of ref document: EP Kind code of ref document: A2 |